Skip to Content
U.S. National Institutes of Health
Last Updated: 01/27/12

Leukemia SPOREs

Despite the fact that major advances in diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a serious medical problem. According to the Leukemia and Lymphoma Society, 43,050 new cases were diagnosed in the United States in 2010 with approximately 11% more cases in chronic leukemia than in acute leukemia.  Leukemia is the most common type of cancer in children ages 0-19 and has a somewhat higher incidence in males than females.  Approximately 22,000 people died of leukemia in 2010.  The incidence and mortality rates for leukemia have decreased slightly over the past 20 years.  The first round of SPORE applications in Leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.  Currently NCI funds two leukemia SPORE grants.

Ohio State University

John Byrd, M.D. [Click Here]
Division of Hematology
Department of Internal Medicine
The Ohio State University Comprehensive Cancer Center
320 West 10th Avenue
B302 Starling Loving Hall
Columbus, Ohio 43210
Tel: (614) 293-8330
Fax: (614) 293-7526
Email: john.byrd@osumc.edu

For more information on this specific SPORE’s institution, please visit:
http://www.cancer.osu.edu/research/cancerresearch/sporegrant/Pages/index.aspx

University of Texas/MD Anderson

Jean Pierre Issa, MD [Click Here]
Associate Professor
University of Texas
M.D. Anderson Cancer Center
Department of Leukemia
1515 Holcombe Boulevard, Box 4
Houston, TX 77030
Tel: (713) 745-2260
Fax: (713) 746-1683
Email: jpissa@mdanderson.org

For more information on this specific SPORE’s institution, please visit:
http://www.mdanderson.org/education-and-research/research-at-md-anderson/early-detection-and-treatment/research-programs/spores/leukemia-spore/index.html